King's College London

Research portal

Early FDG-PET response predicts CAR-T failure in large B-cell lymphoma

Research output: Contribution to journalLetterpeer-review

Andrea Kuhnl, Claire Roddie, Amy A. Kirkwood, Tobias Menne, Maria Cuadrado, Maria A.V. Marzolini, Wendy Osborne, Robin Sanderson, Maeve O’Reilly, William Townsend, Reuben Benjamin, Victoria Potter, Piers E.M. Patten, Deborah Yallop, Stefan Voo, George S. Petrides, Nicola Mulholland, Irfan Kayani

Original languageEnglish
Pages (from-to)321-326
Number of pages6
JournalBlood Advances
Volume6
Issue number1
DOIs
Published11 Jan 2022

Bibliographical note

Funding Information: This work receives funding from the National Institute for Health Research University College London Hospital Biomedical Research Centre (W.T.). I.K. acknowledges funding from the University College London Experimental Cancer Medicine Centre for his post. Funding Information: advisory boards and received honoraria from Kite/Gilead, Novartis, and BMS. A.A.K. has received honoraria from Kite/Gilead. R.S. and M.O. have served on advisory boards and received honoraria from Kite/Gilead and Novartis. T.M. has served on advisory boards and received honoraria from Kite/Gilead, Novartis, BMS, Janssen, Roche, Servier, Pfizer, and Amgen. W.O. has received honoraria from Roche, Takeda, Pfizer, Servier, Kite/Gilead, MSD, Novartis, Bei-gene, Astra Zeneca, Syneos, Autolus, Kyowa Kirin, Abbvie, Incyte, and BMS. W.T. has received honoraria and consultancy fees from Celgene BMS, Incyte, and Roche. V.P. has received honoraria from Kite/Gilead. P.E.M.P. has received research funding from Roche, Kite/Gilead, has served on advisory boards for Novartis and Abbvie, has received honoraria from Abbvie, Astra Zeneca, Gilead, Janssen, and Novartis, and has received support for attending meetings from Abbvie and Janssen. D.Y. has served on advisory boards for Gilead

King's Authors

View graph of relations

© 2020 King's College London | Strand | London WC2R 2LS | England | United Kingdom | Tel +44 (0)20 7836 5454